Finding a genetic diagnosis for one out of 14 subjects with alleged non-syndromic uSNHL as in the present study may still be motivated, but as the risk of progression is low for GJB2/connexin 26-related hearing loss (about 90% are stable over time [48,49]) it may not be high priority. Here, GJB2 is linked to hearing loss disorder.